ALINT IntegraGen SA
0.0676EUR-3.43%Mkt Cap: 486477 $P/E: —1d ago
IntegraGen SA provides researchers with sequencing solutions, data management tools, and biostatistical, and bioinformatics support services in France. The company's genomic pharma services DNA sequencing for oncology an…
Industry Peers
BiotechnologyKey Statistics
Company
Market Cap486.48K USD
Enterprise Value-379.32K USD
Revenue (TTM)5.46M USD
Gross Profit5.45M USD
Net Income (TTM)-186.30K USD
Revenue/Share0.76 EUR
Last Price0.0676 EUR
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees37
CountryFR
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA0.13
EV/Revenue-0.07
P/S0.09
P/B-0.51
EPS (TTM)-0.02
EPS (Forward)—
52W Range
0.06740% of range0.3610
52W High0.3610 EUR
52W Low0.0674 EUR
Profitability
Gross Margin40.03%
Oper. Margin-56.57%
EBITDA Margin-53.92%
Profit Margin-1.37%
ROE-8.52%
ROA-2.14%
Growth
Revenue Growth-44.60%
Earnings Growth—
Cash Flow & Leverage
Operating CF-1.71M USD
CapEx (TTM)—
FCF Margin-3.31%
FCF Yield-37.10%
Net Debt-881.09K USD
Net Debt/EBITDA0.30
Balance Sheet
Debt/Equity0.56
Current Ratio0.95
Quick Ratio0.85
Book Value/Sh-0.14 EUR
Cash/Share0.17 EUR
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 EUR
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.6.61M
Float—
Insiders65.90%
Institutions0.00%
Technical
SMA 500.1525 (-55.7%)
SMA 2000.1692 (-60.1%)
Beta0.34
S&P 52W Chg14.58%
Avg Vol (30d)31.49K
Avg Vol (10d)7.98K
Technical Indicators
RSI (14)22.8
MACD-0.0266
MACD Signal-0.0262
MACD Hist.-0.0004
BB Upper0.2212 EUR
BB Middle0.1054 EUR
BB Lower-0.0103 EUR
BB Width219.60%
ATR (14)0.0074 EUR
Vol Ratio (20d)0.37x